Login / Signup

A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis.

Giulia BandiniAlessia AlunnoFilipe O PinheiroCampochiaro CorradoIlaria GalettiPietro Matucci-CerinicBarbara RuaroKhadija El AoufyMaria R MelisAlberto Moggi PignoneSilvia Bellando RandoneLorenzo DagnaMarco Matucci-CerinicZsuzsanna H McMahanMichael Hughes
Published in: Arthritis care & research (2023)
Despite the frequent use of PPIs in patients with SSc, there is significant heterogeneity in prescription, and combination therapy (PPIs plus other medication for acid reflux) is not uncommon (approximately 40%). Patients have significant concerns about PPIs side effects. Education about PPIs is often neglected, and patients very frequently use online sources to obtain information on drug treatment. A surgical approach is infrequently discussed, and patients fear this potential therapeutic approach.
Keyphrases